← Leaderboards
Matthew Redinbo
Univ Of North Carolina Chapel Hill
$20,283,422
Attributed
$21,065,666
Total exposure
21
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,065,666 · 21
By mechanism
R01$14,421,768 · 8
U01$2,490,382 · 1
P30$1,755,593 · 2
P41$1,296,620 · 9
R35$1,101,303 · 1
Top collaborators
- Sridhar Mani6 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Kate E Coleman$84,678
- Pedro Nicolas Pozo$280,132
- Lydia Patrice Morris$105,724
- Aadra Prashant Bhatt$763,728
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsStructurePharmaceutical PreparationsEnzymesComplexInhibitor/AntagonistBaseAntineoplastic AgentsMolecularIn VitroBacteriaPlayBeta-GlucuronidaseMalignant NeoplasmsStructural BiologyDesignToxic EffectIn VivoLiverDose-LimitingBiologyIrinotecanMicrobialAcute
Grant awards (83)
Gut Microbial Enzymes and Human Disease$536,223
R35 · FY2025 · GM · contact PI
Gut Microbial Enzymes and Human Disease$565,080
R35 · FY2024 · GM · contact PI
Understanding and Controlling Drug Metabolism by the Gut Microbiota to Improve Human Health$304,654
R01 · FY2023 · GM · contact PI
Structural Basis for Hormone and Neurotransmitter Processing by Gut Microbial Enzymes$364,583
R01 · FY2022 · GM · contact PI
Understanding and Controlling Drug Metabolism by the Gut Microbiota to Improve Human Health$304,654
R01 · FY2022 · GM · contact PI
Structural Basis for Hormone and Neurotransmitter Processing by Gut Microbial Enzymes$364,583
R01 · FY2021 · GM · contact PI
Understanding and Controlling Drug Metabolism by the Gut Microbiota to Improve Human Health$304,654
R01 · FY2021 · GM · contact PI
Structural Basis for Hormone and Neurotransmitter Processing by Gut Microbial Enzymes$364,583
R01 · FY2020 · GM · contact PI
Understanding and Controlling Drug Metabolism by the Gut Microbiota to Improve Human Health$318,488
R01 · FY2020 · GM · contact PI
Structural Basis for Hormone and Neurotransmitter Processing by Gut Microbial Enzymes$364,583
R01 · FY2019 · GM · contact PI
Microbiome-Targeted Probes to Eliminate Chemotherapy-Induced GI Toxicity$596,764
R01 · FY2018 · CA · contact PI
Improving CPT-11 Efficacy Using Structural and Chemical Biology$263,899
R01 · FY2018 · CA · contact PI
Microbiome-Targeted Probes to Eliminate Chemotherapy-Induced GI Toxicity$596,764
R01 · FY2017 · CA · contact PI
Improving CPT-11 Efficacy Using Structural and Chemical Biology$263,899
R01 · FY2017 · CA · contact PI
Microbiome-Targeted Probes to Eliminate Chemotherapy-Induced GI Toxicity$552,404
R01 · FY2016 · CA · contact PI
Development of Novel Drugs to Alleviate CPT-11 Toxicity$325,379
R01 · FY2016 · CA
Improving CPT-11 Efficacy Using Structural and Chemical Biology$263,899
R01 · FY2016 · CA · contact PI
Development of Novel Drugs to Alleviate CPT-11 Toxicity$326,465
R01 · FY2015 · CA
Improving CPT-11 Efficacy Using Structural and Chemical Biology$263,899
R01 · FY2015 · CA · contact PI
Structural Biology Core Facility$209,475
P30 · FY2015 · CA · contact PI
Development of Novel Drugs to Alleviate CPT-11 Toxicity$1
R01 · FY2015 · CA
Development of Novel Drugs to Alleviate CPT-11 Toxicity$317,989
R01 · FY2014 · CA
Improving CPT-11 Efficacy Using Structural and Chemical Biology$263,899
R01 · FY2014 · CA · contact PI
Structural Biology Core Facility$201,524
P30 · FY2014 · CA · contact PI
Development of Novel Drugs to Alleviate CPT-11 Toxicity$279,335
R01 · FY2013 · CA
Improving CPT-11 Efficacy Using Structural and Chemical Biology$239,074
R01 · FY2013 · CA · contact PI
Structural Biology Core Facility$205,963
P30 · FY2013 · CA · contact PI
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase$355,517
R01 · FY2012 · AI · contact PI
Development of Novel Drugs to Alleviate CPT-11 Toxicity$315,319
R01 · FY2012 · CA
Improving CPT-11 Efficacy Using Structural and Chemical Biology$254,334
R01 · FY2012 · CA · contact PI
Structural Biology Core Facility$219,024
P30 · FY2012 · CA · contact PI
Structural Biology Core Facility$2,552
P30 · FY2012 · CA · contact PI
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase$355,517
R01 · FY2011 · AI · contact PI
Improving CPT-11 Efficacy Using Structural and Chemical Biology$254,334
R01 · FY2011 · CA · contact PI
Structural Biology Core Facility$220,782
P30 · FY2011 · CA · contact PI
Improving CPT-11 Efficacy Using Structural and Chemical Biology$32,522
R01 · FY2011 · CA · contact PI
Novel Protein-Based Therapeutics for Nerve Agent Detoxification$515,778
U01 · FY2010 · NS · contact PI
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase$410,789
R01 · FY2010 · AI · contact PI
Improving CPT-11 Efficacy Using Structural and Chemical Biology$262,200
R01 · FY2010 · CA · contact PI
Novel Protein-Based Therapeutics for Nerve Agent Detoxification$503,807
U01 · FY2009 · NS · contact PI
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase$362,638
R01 · FY2009 · AI · contact PI
Improving CPT-11 Efficacy Using Structural and Chemical Biology$273,996
R01 · FY2009 · CA · contact PI
CORE--STRUCTURAL BIOLOGY$180,977
P30 · FY2009 · CA · contact PI
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase$46,031
R01 · FY2009 · AI · contact PI
STRUCTURAL STUDIES OF THERAPEUTIC DRUG TARGETS$213
P41 · FY2009 · RR · contact PI
Novel Protein-Based Therapeutics for Nerve Agent Detoxification$458,221
U01 · FY2008 · NS · contact PI
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase$361,268
R01 · FY2008 · AI · contact PI
CORE--STRUCTURAL BIOLOGY$181,172
P30 · FY2008 · CA · contact PI
Novel Protein-Based Therapeutics for Nerve Agent Detoxification$101,793
U01 · FY2008 · NS · contact PI
STRUCTURAL STUDIES OF THERAPEUTIC DRUG TARGETS$573
P41 · FY2008 · RR · contact PI
Novel Protein-Based Therapeutics for Nerve Agent Detoxification$474,981
U01 · FY2007 · NS · contact PI
Improving CPT-11 Efficacy Using Structural Biology$244,473
R01 · FY2007 · CA · contact PI
CORE--STRUCTURAL BIOLOGY$172,630
P30 · FY2007 · CA · contact PI
STRUCTURAL STUDIES OF HUMAN TOPOISOMERASE I AND DRUG PROCESSING ESTERASES$2,775
P41 · FY2007 · RR · contact PI
STRUCTURAL STUDIES OF THERAPEUTIC DRUG TARGETS$199
P41 · FY2007 · RR · contact PI
Novel Protein-Based Therapeutics for Nerve Agent Detoxification$435,802
U01 · FY2006 · NS · contact PI
Structure and Function of the Human Pregnane X Receptor$342,795
R01 · FY2006 · DK · contact PI
Improving CPT-11 Efficacy Using Structural Biology$251,775
R01 · FY2006 · CA · contact PI
CORE--STRUCTURAL BIOLOGY$81,940
P30 · FY2006 · CA · contact PI
STRUCTURAL STUDIES OF HUMAN TOPOISOMERASE I AND DRUG PROCESSING ESTERASES$219
P41 · FY2006 · RR · contact PI
Structure and Function of the Human Pregnane X Receptor$347,122
R01 · FY2005 · DK
Improving CPT-11 Efficacy Using Structural Biology$257,834
R01 · FY2005 · CA
CORE--STRUCTURAL BIOLOGY$79,554
P30 · FY2005 · CA
STRUCTURAL STUDIES OF HUMAN TOPOISOMERASE I AND DRUG PROCESSING ESTERASES$1,429
P41 · FY2005 · RR
Structure and Function of the Human Pregnane X Receptor$347,122
R01 · FY2004 · DK
Improving CPT-11 Efficacy Using Structural Biology$257,834
R01 · FY2004 · CA
Structure and Mechanism of Human Topoisomerase I$211,339
R01 · FY2004 · CA
STRUCTURE--HUMAN TOPOISOMERASE I &DRUG PROCESS ESTERASE$2,628
P41 · FY2004 · RR
Structure and Function of the Human Pregnane X Receptor$343,385
R01 · FY2003 · DK
Improving CPT-11 Efficacy Using Structural Biology$265,933
R01 · FY2003 · CA
Structure and Mechanism of Human Topoisomerase I$211,339
R01 · FY2003 · CA
Structure and Function of the Human Pregnane X Receptor$343,385
R01 · FY2002 · DK
Structure and Mechanism of Human Topoisomerase I$211,339
R01 · FY2002 · CA
CRYSTALLOGRAPHIC STUDIES OF HUMAN TOPOISOMERASE I DNA$143,176
P41 · FY2002 · RR
CRYSTALLOGRAPHIC STUDIES OF HUMAN TOPOISOMERASE I$143,176
P41 · FY2002 · RR
CRYSTALLOGRAPHIC STUDIES OF HUMAN TOPOISOMERASE I$143,176
P41 · FY2002 · RR
CRYSTALLOGRAPHIC STUDIES OF HUMAN TOPOISOMERASE I DNA COMPLEX$143,176
P41 · FY2002 · RR
CRYSTALLOGRAPHIC STUDIES OF HUMAN TOPOISOMERASE I DNA COMPLEX$143,176
P41 · FY2002 · RR
CRYSTALLOGRAPHIC STUDIES OF HUMAN TOPOISOMERASE I DNA$143,176
P41 · FY2002 · RR
Structure and Mechanism of Human Topoisomerase I$257,176
R01 · FY2001 · CA
CRYSTALLOGRAPHIC STUDIES OF HUMAN TOPOISOMERASE I DNA COMPLEX$143,176
P41 · FY2001 · RR
CRYSTALLOGRAPHIC STUDIES OF HUMAN TOPOISOMERASE I$143,176
P41 · FY2001 · RR
CRYSTALLOGRAPHIC STUDIES OF HUMAN TOPOISOMERASE I DNA$143,176
P41 · FY2001 · RR